TIM23 Antibody

What is the TIM23 complex and why is it important for mitochondrial research?

The TIM23 complex is a crucial component of the protein import machinery in the mitochondrial inner membrane. Tim23 serves as a key component of this preprotein translocase, anchored in the inner membrane by its C-terminal domain while exposing an intermediate domain in the intermembrane space that functions as a presequence receptor . The complex facilitates the translocation of nuclear-encoded mitochondrial proteins across the inner membrane, making it essential for mitochondrial biogenesis and function . Research targeting Tim23 helps elucidate fundamental mechanisms of mitochondrial protein import, which is critical for understanding mitochondrial disorders and cellular energetics.

What are the optimal applications for TIM23 antibody in experimental research?

TIM23 antibody can be effectively utilized in multiple experimental applications:

• Western Blot (WB): Recommended dilution of 1:1000-1:10000, with documented reactivity in human, mouse, and rat samples including various cell lines (HeLa, MCF-7, Jurkat, K-562, NIH/3T3) and tissue specimens

• Immunoprecipitation (IP): Use 0.5-4.0 μg antibody for 1.0-3.0 mg of total protein lysate

• Immunohistochemistry (IHC): Optimal dilution of 1:50-1:500 with successful detection in human testis and mouse heart tissue

• Immunofluorescence (IF/ICC): Effective at 1:200-1:1600 dilution with positive detection in HepG2 cells

These applications make TIM23 antibody versatile for protein localization, quantification, and interaction studies in mitochondrial research.

What is the molecular weight profile of TIM23 and how does this affect antibody recognition?

TIM23 has both a calculated and observed molecular weight of 22 kDa as determined by SDS-PAGE analysis . This consistency between theoretical and experimental weights indicates minimal post-translational modifications affecting migration patterns. When interpreting Western blot results, researchers should expect a single band at approximately 22 kDa when using appropriately validated TIM23 antibodies. Any additional bands may indicate degradation products, splice variants, or non-specific binding that requires further optimization.

How should I design experiments to investigate TIM23 complex integrity and function?

When investigating TIM23 complex integrity and function, consider these methodological approaches:

• Co-immunoprecipitation studies: Target TIM23 and probe for associated proteins (Tim17, Tim21, Tim44, Pam16, Pam18) to assess complex formation. For example, antibodies against Tim23p have been shown to effectively immunoprecipitate the TIM23 complex .

• Blue-native PAGE analysis: This technique effectively separates different forms of the TIM23 complex while maintaining native protein interactions. Previous research has identified multiple TIM23 complexes including the core Tim23-17 complex (~100 kD), Tim23-17-21 complex, and larger Tim23-17-21-50 complex .

• Glycerol density gradient centrifugation: This approach can separate protein complexes based on size, allowing you to assess TIM23 complex integrity. Research has shown the TIM23 complex components Tim23, Tim17, and Tim44 are typically found in fractions corresponding to higher molecular weights (~250 kD) in wild-type mitochondria .

• Channel conductance measurements: To assess TIM23 function, experiments measuring the mitochondrial inner membrane channel (MCC) conductance have been effective, particularly when exposed to mitochondrial presequence peptides .

Include appropriate controls such as preimmune IgG alongside anti-TIM23 antibodies and use both wild-type and mutant (e.g., tim23-1) samples for comparison.

What are the critical controls for TIM23 antibody experiments to ensure reliable results?

Implementing appropriate controls is crucial for TIM23 antibody experiments:

• Negative controls:

  • Preimmune IgG at equivalent concentrations to test for non-specific binding

  • Isotype-matched control antibodies

  • Samples with TIM23 knockdown/knockout (validated in at least 2 publications)

• Positive controls:

  • Known TIM23-expressing samples (HeLa, MCF-7, Jurkat, K-562, NIH/3T3 cells, heart tissue)

  • Recombinant TIM23 protein

• Specificity controls:

  • Antibodies against other mitochondrial proteins (VDAC for outer membrane, Rieske iron-sulfur protein)

  • Peptide competition assays

  • Mitochondrial fractionation to confirm localization to inner membrane

• Method-specific controls:

  • For IHC/IF: Secondary antibody-only controls

  • For WB: Molecular weight markers and loading controls (ideally other mitochondrial proteins)

  • For IP: Input, flow-through, and non-specific bead binding controls

How can I verify subcellular localization of TIM23 in different experimental systems?

To verify TIM23 subcellular localization:

• Subcellular fractionation: Isolate mitochondria using established protocols (e.g., Daum et al., 1982), then separate outer and inner mitochondrial membranes using the French press method followed by centrifugation . Analyze fractions by Western blotting using antibodies against:

  • TIM23 (inner membrane marker)

  • VDAC (outer membrane marker)

  • Matrix proteins (e.g., HSP60)

  • Cytosolic markers (e.g., GAPDH)

• Immunofluorescence co-localization:

  • Co-stain with TIM23 antibody (1:400-1:1600 dilution) and mitochondrial markers like MitoTracker

  • Use super-resolution microscopy for detailed submitochondrial localization

  • Analyze using colocalization coefficients (Pearson's or Mander's)

• Immunoelectron microscopy:

  • Provides precise submitochondrial localization

  • Confirm TIM23 localization specifically at the inner membrane

• Protease protection assays:

  • Treat intact mitochondria, mitoplasts (outer membrane removed), and solubilized mitochondria with proteases

  • Assess TIM23 degradation patterns to confirm topology

How do mutations in the TIM23 complex affect import function and how can antibodies help investigate this?

Studies comparing wild-type and mutant TIM23 complexes have revealed important insights about functional consequences:

• Functional impacts of mutations:

  • The tim23-1 mutation significantly alters MCC channel activity, particularly its response to mitochondrial presequence peptides . Unlike wild-type MCC, the conductance of MCC from tim23-1 mutants is not significantly blocked by presequence peptides, indicating disrupted signal recognition.

  • Tam41 depletion causes Tim23, Tim17, and Tim44 to shift toward fractions of lower molecular weight in glycerol density gradient centrifugation, suggesting complex destabilization .

• Antibody-based investigation approaches:

  • Comparative co-immunoprecipitation using TIM23 antibodies in wild-type versus mutant backgrounds can reveal altered protein interactions

  • Blue-native PAGE combined with immunoblotting using TIM23 antibodies can identify structural changes in complex formation

  • Antibody inhibition experiments comparing effects on wild-type versus mutant protein import can elucidate functional consequences

• Methodological considerations:

  • When investigating Tim23 mutations, always include wild-type controls processed identically

  • For quantitative comparisons, use densitometry analysis of Western blots with appropriate normalization

  • Consider temperature-sensitive mutations (like tim23-1) and appropriate experimental conditions

What techniques can resolve contradictory results when studying TIM23 complex composition?

When confronting contradictory results regarding TIM23 complex composition:

• Cross-validation approaches:

  • Combine multiple techniques (co-IP, BN-PAGE, density gradient centrifugation)

  • Use different antibodies targeting various TIM23 complex components

  • Apply both forward and reverse co-immunoprecipitation (e.g., using Tim23-FLAG and reciprocally using antibodies against potential interactors)

• Address specific contradictions:

  • The exclusivity of Tim21 and Pam18-Pam16-Tim44 in the TIM23 complex has been questioned. While some studies proposed they are mutually exclusive, other evidence shows Tim21 shifts alongside Pam components upon Tam41 depletion . This contradiction can be resolved using:

    • Immunoprecipitation with FLAG-tagged Tim21 or Pam16

    • Sequential immunoprecipitation to identify subpopulations

    • Quantitative analysis of component stoichiometry

• Methodological refinements:

  • Vary detergent types and concentrations to preserve different interaction strengths

  • Use chemical crosslinking prior to solubilization

  • Consider dynamic vs. stable interactions by varying salt concentrations

• Advanced structural approaches:

  • Cryo-EM analysis with antibody fragments as fiducial markers has significantly improved resolution of TIM23 complex structure from ~8Å to 2.7Å

  • Mass spectrometry-based approaches to identify all components in purified complexes

How can antibodies against TIM23 be used to investigate dynamic assembly and disassembly of import complexes?

TIM23 antibodies can be powerful tools for studying the dynamic nature of mitochondrial import complexes:

• Pulse-chase experiments:

  • Import radiolabeled precursor proteins into isolated mitochondria

  • At various time points, solubilize and immunoprecipitate with TIM23 antibody

  • Analyze the transient association of precursors with the TIM23 complex

  • Research has successfully used this approach with imported radiolabeled Tim23 to identify different forms of TIM23 complexes

• In organello dynamics:

  • Isolate mitochondria and subject them to various conditions (ATP depletion, membrane potential disruption)

  • Solubilize and analyze TIM23 complex composition by co-IP or BN-PAGE

  • Compare the stability of different complex components under various conditions

• Real-time imaging approaches:

  • Use fluorescently labeled TIM23 antibody fragments in permeabilized cells

  • Monitor complex assembly/disassembly using FRAP (Fluorescence Recovery After Photobleaching) or FRET (Förster Resonance Energy Transfer)

• Quantitative analysis of complex stoichiometry:

  • Use a combination of western blotting with TIM23 antibodies and mass spectrometry

  • Determine the relative abundance of different complex components under various conditions

What are common technical issues with TIM23 antibody applications and how can they be resolved?

How can I optimize isolation of intact TIM23 complex for structural and functional studies?

For optimal isolation of intact TIM23 complex:

• Mitochondrial isolation:

  • Use gentle isolation methods that preserve organelle integrity

  • Include protease inhibitors throughout all steps

  • Work quickly and keep samples cold (4°C)

• Solubilization optimization:

  • Digitonin (1%) is preferred over harsher detergents for maintaining complex integrity

  • Maintain physiological pH (7.2-7.4) and salt concentration

  • Include ATP and/or GTP (1-2 mM) to stabilize certain interactions

  • Consider chemical crosslinking prior to solubilization to capture transient interactions

• Purification approaches:

  • Utilize epitope-tagged versions of Tim23 (FLAG-tagged Tim23 has been successfully used)

  • For antibody-based purification, use mild elution conditions (competitive peptide elution rather than low pH)

  • Consider glycerol density gradient centrifugation to separate intact complexes (~250 kD) from subcomplexes or aggregates

  • Blue-native PAGE can effectively separate different forms of the TIM23 complex while maintaining native interactions

• Quality control:

  • Analyze samples by Western blotting for all known components

  • Negative stain electron microscopy to confirm structural integrity

  • Functional assays (e.g., reconstitution into liposomes for channel activity)

• Advanced structural approaches:

  • For cryo-EM studies, consider using monoclonal antibody fragments as fiducial markers to improve resolution, as demonstrated with Tim44-CTD

What methodological considerations are important when analyzing TIM23 complex by Blue-Native PAGE?

Blue-Native PAGE has been instrumental in analyzing TIM23 complex composition and can be optimized with these considerations:

• Sample preparation:

  • Digitonin (1%) solubilization preserves native interactions better than other detergents

  • Protein:detergent ratio is critical - typically 1:4 to 1:6 (w/w)

  • Include Coomassie Blue G-250 (0.25-0.5%) in sample buffer

  • Avoid reducing agents and heat denaturation

• Gel system optimization:

  • Gradient gels (3-12% or 4-16%) provide better resolution of different complexes

  • First dimension BN-PAGE can be followed by second dimension SDS-PAGE for subunit analysis

  • Include proper molecular weight standards suitable for native PAGE

• Expected complex visualization:

  • Tim23 and Tim17 core complex: ~100 kD

  • TIM23 complex containing Tim21: slightly larger

  • TIM23 complex with Tim50 and Tim21: largest form

  • When analyzing immunoblots, probe for multiple components to confirm complex identity

• Troubleshooting tips:

  • If complexes dissociate: reduce salt concentration, increase digitonin, keep samples cold

  • If smearing occurs: reduce sample load, optimize Coomassie concentration

  • For improved resolution of similarly sized complexes: run gels at lower voltage for longer time

• Verification strategies:

  • Antibody supershift assays can confirm complex composition (adding antibodies prior to electrophoresis)

  • Identification of complex components can be achieved using FLAG-tagged components and immunoblotting

How should researchers interpret changes in TIM23 expression levels in relation to mitochondrial dysfunction?

When interpreting TIM23 expression changes:

• Context-dependent interpretation:

  • Decreased TIM23 expression may indicate mitochondrial import defects, reduced mitochondrial biogenesis, or selective mitophagy

  • Increased TIM23 expression often represents compensatory upregulation in response to mitochondrial stress or increased biogenesis demand

  • Always normalize TIM23 levels to multiple mitochondrial markers representing different compartments (outer membrane, matrix)

• Validation approaches:

  • Confirm findings with multiple techniques (WB, qPCR, IF)

  • Correlate TIM23 changes with functional measures (import assays, respiratory capacity)

  • Determine if changes are selective for TIM23 or affect other import components similarly

• Common patterns in research findings:

  • TIM23 expression changes often parallel alterations in mitochondrial mass

  • Post-translational modifications may alter function without changing expression level

  • Changes in complex assembly may be more informative than total protein levels

• Methodological considerations:

  • For accurate quantification, use appropriate normalization (mitochondrial housekeeping proteins)

  • Consider subcellular fractionation to distinguish changes in mitochondrial content from changes in TIM23 expression within mitochondria

  • When possible, measure both mRNA and protein levels to distinguish transcriptional from post-transcriptional regulation

How can researchers use TIM23 antibodies to investigate mitochondrial protein import defects in disease models?

TIM23 antibodies enable multifaceted investigation of import defects:

• Import assay optimization:

  • Isolate mitochondria from control and disease models

  • Use in vitro translated radiolabeled precursor proteins

  • Monitor import kinetics and efficiency

  • Add TIM23 antibodies (0.5-4.0 μg) to assess specific inhibition of the TIM23 pathway

• Structural analysis of import complexes:

  • BN-PAGE combined with immunoblotting using TIM23 antibodies can reveal altered complex formation in disease states

  • Co-immunoprecipitation with TIM23 antibodies to assess changes in interacting partners

  • Compare the distribution of TIM23 complexes between control and disease samples using glycerol density gradient centrifugation

• Import pathway selectivity:

  • Compare effects on TIM23-dependent vs. TIM23-independent import pathways

  • Analyze import of matrix proteins (using presequences) vs. inner membrane proteins (using internal targeting signals)

  • Determine if defects are general or substrate-specific

• In situ analysis in cellular models:

  • Use split-GFP or FRET-based reporters combined with immunofluorescence against TIM23

  • Monitor import in live cells with fluorescent precursors

  • Apply super-resolution microscopy to examine TIM23 distribution and clustering

• Therapeutic screening applications:

  • Screen compounds for rescue of import defects

  • Use TIM23 antibodies to monitor complex integrity upon treatment

  • Assess normalization of interaction partners following intervention

What advances in structural biology techniques have enhanced our understanding of the TIM23 complex?

Recent structural biology advances have significantly improved our understanding of TIM23:

• Cryo-electron microscopy breakthroughs:

  • Initial cryo-EM analysis of overexpressed TIM23 complex yielded only low (~8-Å) resolution

  • Development of monoclonal antibodies against Tim44-CTD and use of antigen-binding fragment (Fab) as a fiducial marker dramatically increased resolution to 2.7 Å

  • This higher resolution enabled atomic modeling of a core complex composed of Tim17, Tim23, and Tim44

• Integrated structural approaches:

  • Combination of X-ray crystallography data with cryo-EM maps

  • The Tim44-CTD model from cryo-EM could be superposed with its previous crystal structure

  • Cross-linking mass spectrometry to validate structural models and identify dynamic interfaces

• Technical innovations facilitating structural studies:

  • Antibody fragment application as fiducial markers

  • Expression and purification strategies for membrane protein complexes

  • Advanced image processing algorithms

• Functional correlations with structure:

  • Channel conductance studies with MCC (TIM23 channel) showed specific blocking by mitochondrial import signals

  • Antibodies against Tim23p inhibit both MCC activity and mitochondrial protein import

  • Mutations like tim23-1 alter both structure and function, particularly response to presequence peptides

• Future directions:

  • Capturing transient states during protein translocation

  • Structural changes upon substrate binding

  • Conformational dynamics during the import cycle

What emerging technologies might enhance TIM23 complex research beyond current antibody-based approaches?

Several emerging technologies hold promise for advancing TIM23 research:

• Proximity labeling techniques:

  • BioID or APEX2 fused to TIM23 can identify transient interactors

  • Allows mapping of dynamic protein interactions during import process

  • Can identify novel components not stable enough for traditional co-IP

• Single-molecule approaches:

  • FRET-based sensors to monitor conformational changes during import

  • Optical tweezers to measure force generation during translocation

  • Single-particle tracking in live cells to monitor complex dynamics

• Advanced imaging techniques:

  • Super-resolution microscopy (STORM, PALM) for submitochondrial localization

  • Correlative light and electron microscopy (CLEM) linking function to structure

  • Live-cell imaging with split fluorescent proteins to visualize import in real-time

• CRISPR-based technologies:

  • CRISPR interference/activation for precise regulation of TIM23 expression

  • Base editing for introducing specific mutations to probe structure-function

  • CRISPR screens to identify novel regulators of TIM23 complex function

• Computational approaches:

  • Molecular dynamics simulations of the TIM23 channel

  • Machine learning algorithms to predict import efficiency based on precursor features

  • Systems biology integration of proteomics, transcriptomics, and metabolomics data

These approaches will complement antibody-based methods and potentially overcome current limitations in studying dynamic and transient aspects of TIM23 function.

How can researchers effectively combine multiple approaches to address conflicting models of TIM23 complex structure and function?

Resolving conflicting models requires methodological integration:

• Systematic validation strategy:

  • Test each model using multiple orthogonal techniques

  • Explicitly address contradictions between models in experimental design

  • The debate regarding Tim21 and Pam18-Pam16-Tim44 exclusivity can be addressed through:

    • Quantitative assessment of component stoichiometry

    • Single-particle analysis to identify distinct complex populations

    • Functional correlation with structural variations

• Contextual considerations:

  • Different experimental conditions may support different models

  • Evaluate dynamic vs. static complex states

  • Consider organism-specific and tissue-specific variations

• Integrative experimental approach:

  • Combine structural methods (cryo-EM, crosslinking) with functional assays

  • Link biochemical observations to physiological outcomes

  • Use both in vitro reconstitution and in vivo studies

• Data standardization and sharing:

  • Establish commonly accepted benchmarks and controls

  • Develop standardized protocols for complex isolation and analysis

  • Create repositories for structural data and raw experimental results